Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) $ in Millions	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2024 € / shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 € / shares
Cash and cash equivalents, including restricted cash	$ 951		$ 1,000
Accounts receivable	4,613		1,806
Other non-current assets	2,354		601
Non-current debt due after one year	13,174		3,669
Other non-current liabilities	$ 2,267		$ 385
Preferred stock, par or stated value per share (in euro per share) | $ / shares	$ 0.001		$ 0.001
Preferred stock, shares authorized (in shares) | shares	500,000,000		0
Preferred stock, shares outstanding (in shares) | shares	10,000		0
Common stock, par or stated value per share (in euro per share) | $ / shares	$ 0.001		$ 0.001
Common stock, shares authorized (in shares) | shares	9,500,000,000		9,910,931,085
Common stock, shares outstanding (in shares) | shares	520,056,084		260,354,342
Deferred stock, par or stated value per share (in euro per share) | € / shares		€ 1		€ 1
Deferred stock, shares authorized (in shares) | shares	25,000		25,000
Deferred stock, shares outstanding (in shares) | shares	25,000		100
Treasury stock, common (in shares) | shares	2,037,589		1,907,129
Variable interest entity, primary beneficiary
Cash and cash equivalents, including restricted cash	$ 3		$ 3
Accounts receivable	823		816
Other non-current assets	390		0
Non-current debt due after one year	337		20
Other non-current liabilities	$ 334		$ 0